Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis

AMRX

Market Closed

Amneal Pharmaceuticals, Inc.

NASDAQHealthcare Drug Manufacturers - Specialty & Generic

8.30K employees

CEO: Chirag K. Patel

Founded: 2018

$16.34

+$0.00(+NaN%)

Market Cap

5.21B

Beta

1.32

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

AMRX Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for AMRX built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

42.86%

Score

3/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$15.34

AI Price Target

Machine learning • Price prediction

$16.19

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

2.24

Quality Score

Financial strength rating

7.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting AMRX investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

64.10% Good

Conditions Met

25.00/39.00

Due Diligence Score

64.10%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions